Browsing: Weight Loss

Eli Lilly on Thursday said it will file for approval of its next-generation obesity drug in the first quarter of 2027, as the treatment succeeds in two more late-stage trials. 

The increased use of weight-loss drugs has created a big opportunity for aesthetics company Galderma, its CEO told CNBC on Thursday

ByJasmine Laws Newsweek is a Trust Project member See more of our trusted coverage when you search.to see more of our trusted coverage when you search.

Recruitment of 11.5 billion won for misleading advertisements on drugs such as ‘food intake inhibitors and fat emission agents’Exaggeration of effects on simple olive oil and lemon juice products ‘detox and slow aging’ a photograph of a major misrepresentation. [Presidence]

Foods That Naturally Support GLP-1: What to Eat for Fullness and Weight Management HEADLINES: | HEADLINES: | Wellness Foods That Naturally Support GLP-1: What to Eat for Fullness and Weight Management Arci Claveria Published July 23, 2026 01:00 PM PHT  |  Updated July 23, 2026 01:13 PM PHT ADVERTISEMENT Read More: What to Eat for…

Healthy Weight for You (H-WFU) is a free, six-month weight management program offered by Wake Forest University’s Healthy Exercise and Lifestyle ProgramS (HELPS) exclusively for full-time, permanent employees. Designed for individuals who want to lose weight but are unsure where to begin, this medically directed and professionally supervised program goes beyond traditional lifestyle changes with…

JAKARTA – Every child has the right to grow healthy and achieve the best future. On the momentum of this year’s National Children’s Day, the joint commitment to strengthen children’s health is becoming increasingly important, especially in the midst of increasing prevalence of obesity and the need for optimal access to treatment for children with…

Semaglutide, a diabetes and obesity medication sold under brand names such as Wegovy and Ozempic, has been shown in a large-scale study to significantly reduce the risk of seizures that first occur in adulthood. The findings suggest that semaglutide may help protect brain health. 

Two pharmaceutical giants that dominate the global obesity drug market have clashed over advertising for their obesity treatments. Analysts say the fight to seize control of the rapidly growing obesity drug market, now worth hundreds of billions of dollars, has intensified. 

Why India’s silent liver epidemic is also a cardiovascular crisis – The South First | News, Politics, Sports, Entertainment & Live Updates ${author.name} `; }); } else { authorsHTML = `